BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26289972)

  • 41. Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications.
    McKinnon JE; Maksimowicz-McKinnon K
    Transl Res; 2016 Jan; 167(1):46-60. PubMed ID: 26408802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recommended immunization practices for pediatric renal transplant recipients.
    Neu AM; Fivush BA
    Pediatr Transplant; 1998 Nov; 2(4):263-9. PubMed ID: 10084727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine-preventable diseases.
    J Okla State Med Assoc; 2000 Dec; 93(12):567-8. PubMed ID: 11197952
    [No Abstract]   [Full Text] [Related]  

  • 44. Vaccination recommendations for patients with neuromuscular disease.
    Esposito S; Bruno C; Berardinelli A; Filosto M; Mongini T; Morandi L; Musumeci O; Pegoraro E; Siciliano G; Tonin P; Marrosu G; Minetti C; Servida M; Fiorillo C; Conforti G; Scapolan S; Ansaldi F; Vianello A; Castaldi S; Principi N; Toscano A; Moggio M
    Vaccine; 2014 Oct; 32(45):5893-900. PubMed ID: 25223270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [My patient will receive immunosuppressive therapy : which vaccination for each situation ?].
    Moschouri E; Bart PA
    Rev Med Suisse; 2016 Nov; 12(540):1997-2002. PubMed ID: 28696606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Food allergies are rarely a concern when considering vaccines for adolescents.
    Buyantseva LV; Horwitz A
    J Am Osteopath Assoc; 2014 Mar; 114(3 Suppl 1):S18-21. PubMed ID: 24636969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical epidemiology of infectious disease among patients with chronic kidney disease.
    Ishigami J; Matsushita K
    Clin Exp Nephrol; 2019 Apr; 23(4):437-447. PubMed ID: 30178234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.
    Paulo AC; Gomes MC; Casinhas AC; Horta A; Domingos T
    IMA J Math Appl Med Biol; 2000 Sep; 17(3):201-12. PubMed ID: 11103718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination in patients with chronic kidney disease-Review of current recommendations and recent advances.
    Ma BM; Yap DYH; Yip TPS; Hung IFN; Tang SCW; Chan TM
    Nephrology (Carlton); 2021 Jan; 26(1):5-11. PubMed ID: 32524684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunizations in the United States: success, structure, and stress.
    Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
    Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination and herd immunity: what more do we know?
    Rashid H; Khandaker G; Booy R
    Curr Opin Infect Dis; 2012 Jun; 25(3):243-9. PubMed ID: 22561998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease.
    Wang YM; Zhou JJ; Wang Y; Watson D; Zhang GY; Hu M; Wu H; Zheng G; Wang Y; Durkan AM; Harris DC; Alexander SI
    Int J Clin Exp Pathol; 2013; 6(3):326-33. PubMed ID: 23412421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization in the adult immunocompromised host.
    Löbermann M; Boršo D; Hilgendorf I; Fritzsche C; Zettl UK; Reisinger EC
    Autoimmun Rev; 2012 Jan; 11(3):212-8. PubMed ID: 21621004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Many Faces of Infection in CKD: Evolving Paradigms, Insights, and Novel Therapies.
    Narayanan M
    Adv Chronic Kidney Dis; 2019 Jan; 26(1):5-7. PubMed ID: 30876617
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune recognition, control of infections and vaccination strategies.
    Ciba Found Symp; 1997; 204():142-7. PubMed ID: 9107417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.